Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1017783-03-7

Post Buying Request

1017783-03-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1017783-03-7 Usage

General Description

5-Bromo-2-(4-morpholinyl)-3-pyridinecarboxylic acid is a chemical compound that consists of a pyridine ring with a bromine atom at the 5 position and a carboxylic acid group at the 3 position. It also contains a 4-morpholinyl substituent, which is a heterocyclic amine with a morpholine ring. 5-Bromo-2-(4-morpholinyl)-3-pyridinecarboxylic acid has potential applications in medicinal chemistry, particularly as a building block for the synthesis of pharmaceuticals and biologically active molecules. Its diverse structure and functional groups make it a versatile intermediate for the development of new drugs or chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 1017783-03-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,7,7,8 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1017783-03:
(9*1)+(8*0)+(7*1)+(6*7)+(5*7)+(4*8)+(3*3)+(2*0)+(1*3)=137
137 % 10 = 7
So 1017783-03-7 is a valid CAS Registry Number.

1017783-03-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-2-morpholin-4-ylpyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-bromo-2-morpholinonicotinic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1017783-03-7 SDS

1017783-03-7Relevant articles and documents

COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS

-

Page/Page column 161, (2019/04/26)

The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

COMPOUNDS ACTIVE TOWARDS BROMODOMAINS

-

Page/Page column 318; 319, (2016/05/02)

Disclosed are compounds towards bromodomains, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1017783-03-7